CEFEPIME TAMRISA 1 g, powder for solution for injection (IM/IV) bottle
Active ingredients: Cefepime, Cefepime hydrochloride hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injectionbottleintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFEPIME TAMRISA 1 g, poudre pour solution injectable (IM/IV)
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- TAMRISA ACCESS (FRANCE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Sept 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69013007CIP72732345CIP133400927323454Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFÉPIMEpoudre | 1 g · un flacon de poudre | FT |
| DICHLORHYDRATE DE CÉFÉPIME MONOHYDRATÉpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.